Oncology Newswire

Oncology Newswire

Comprehensive Real-Time News Feed for Oncology.

Results 1 - 20 of 9,959 in Oncology

  1. 3 Reasons Why Incyte Corporation Stock Could Soar in 2017Read the original story w/Photo

    11 min ago | The Motley Fool

    ... with momelotinib. Gilead's CEO John Milligan stated that the big biotech is especially interested in beefing up its oncology portfolio . Incyte would check off that box perhaps better than any other company. However, Milligan has also said that some ...

    Comment?

  2. Rivier fills a need for needyRead the original story w/Photo

    1 hr ago | Lowell Sun

    ... Mental Health at Community Council, Healthy at Home, HIV/AIDS Task Force, Keystone Hall, Nashua Foundation for Oncology/Hematology, Nashua Soup Kitchen and Shelter NH Catholic Charities, The Salvation Army, Title One and, for the first time ...

    Comment?

  3. Meds don't cut trastuzumab-tied left ventricular remodelingRead the original story w/Photo

    1 hr ago | PhysOrg Weblog

    For patients with human epidermal growth factor receptor 2-overexpressing early breast cancer, perindopril and bisoprolol do not prevent trastuzumab-mediated left ventricular remodeling, according to a study published online Nov. 28 in the Journal of Clinical Oncology . Edith Pituskin, R.N., Ph.D., from the University of Alberta in Edmonton, Canada, and colleagues conducted a placebo-controlled trial involving patients with HER2-positive early breast cancer.

    Comment?

  4. EXCHANGE: Rockford firefighters help veteran battling cancerRead the original story

    5 hrs ago | Washington Times

    Three months ago Anthony Johnson received a diagnosis of Stage 2 rectal cancer. Today he was given a promising outlook from his oncologist, along with a check for $3,600.

    Comment?

  5. Immunogenic peptide discovery in cancer genomesRead the original story

    7 hrs ago | CiteULike

    ... neoantigen prediction will be reviewed here, along with the most important examples of their use in the field of oncology. CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes ...

    Comment?

  6. Leader of MD Anderson Cancer - Moon Shots' Program To Speak in Tyler December 3Read the original story w/Photo

    7 hrs ago | Gilmer Mirror

    ... control, innovations in technology, supportive care and palliative medicine, immunotherapy advancements, surgical oncology for the pancreas and liver, lung cancer screening, and cancer-related plastic surgery. Speakers for the medical conference ...

    Comment?

  7. Amgen Announces Launch Of Blood Counts And Collaboration With...Read the original story

    11 hrs ago | KTMF

    ... awareness of this incurable disease through the power of storytelling," said , vice president and general manager, Oncology Business Unit at Amgen. "We encourage those impacted by multiple myeloma to join us in this effort and sign up to share their ...

    Comment?

  8. ValiRx Plc (VAL) Earns "Corporate" Rating from Northland SecuritiesRead the original story w/Photo

    11 hrs ago | Daily Political

    ... ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and ...

    Comment?

  9. Childrens Hospital of Pittsburgh of UPMC Oncologist Receives St....Read the original story

    13 hrs ago | PressReleasePoint

    To conduct innovative research and give more children the opportunity to participate in clinical trials, Jean M. Tersak, M.D. , an oncologist in the Division of Pediatric Hematology/Oncology at Children's Hospital of Pittsburgh of UPMC , has been awarded a one-year, $50,000 grant from the St. Baldrick's Foundation , a volunteer-powered charity dedicated to raising money for childhood cancer research. Dr. Tersak's is one of 40 infrastructure grants totaling more than $2.5 million awarded by St. Baldrick's to support pediatric oncology research.

    Comment?

  10. Genesis HealthCare Cancer Care CenterRead the original story w/Photo

    13 hrs ago | Contract

    ... Care Center in Zanesville, Ohio, SmithGroupJJR worked with the client to unify two cancer care practices-radiation oncology and medical oncology-into one patient-focused facility within the Genesis HealthCare campus. The new two-story ambulatory ...

    Comment?

  11. ARIAD to Host Webcast and Conference Call on Brigatinib Data...Read the original story

    13 hrs ago | Customer Interaction Solutions

    ... host the call. Dr. Clackson will be joined by Karen Reckamp, MD, associate professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Lung Cancer and Thoracic Oncology Program at City of Hope Comprehensive Cancer ...

    Comment?

  12. a I didna t get ita : Oncology nurse writes note to patients after own diagnosisRead the original story w/Photo

    14 hrs ago | WXMI-TV Grand Rapids

    Lindsay Norris has a lot to say to the cancer patients she's helped in her role as an oncology nurse, but in a recent blog post she penned after finding out she has cancer herself, the prevailing theme is: "I didn't get it." Per People , Norris was diagnosed with stage 3 colorectal adenocarcinoma in September, and that diagnosis has been an eye-opener for the 33-year-old mom from Kansas.

    Comment?

  13. 'I Didn't Get It': Oncology Nurse Writes Note To Patients After Own DiagnosisRead the original story w/Photo

    15 hrs ago | 5NEWSonline.com

    Lindsay Norris has a lot to say to the cancer patients she's helped in her role as an oncology nurse, but in a recent blog post she penned after finding out she has cancer herself, the prevailing theme is: "I didn't get it." Per People , Norris was diagnosed with stage 3 colorectal adenocarcinoma in September, and that diagnosis has been an eye-opener for the 33-year-old mom from Kansas.

    Comment?

  14. Regenacy Pharmaceuticals to be Launched by Acetylon Pharmaceuticals...Read the original story

    15 hrs ago | Customer Interaction Solutions

    ... among other things, worldwide rights to Acetylon's selective HDAC6 inhibitor programs and intellectual property in oncology, neurodegeneration, and autoimmune disease, including its lead drug candidates citarinostat (ACY-241) and ricolinostat ...

    Comment?

  15. Renal Cell Carcinoma - Pipeline Review, H2 2016; New Report LaunchedRead the original story w/Photo

    16 hrs ago | SBWire

    ... pipeline guide Renal Cell Carcinoma - Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape. Renal cell carcinoma (RCC, formerly known as hypernephroma) is a kidney cancer that originates in the ...

    Comment?

  16. LoveLights event is Dec. 6 -Read the original story w/Photo

    17 hrs ago | Newberry Observer

    ... exceptional healthcare to patients and their families. "Most of the time, money goes to support something like the Oncology Department or our New Beginnings Department. We usually try to pick something that everybody's been touched with, whether ...

    Comment?

  17. Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016; New Report LaunchedRead the original story w/Photo

    17 hrs ago | SBWire

    ... Carcinoma - Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology) pipeline landscape. Head and Neck Cancer Squamous Cell Carcinoma is a cancer that arises in the head or neck region (in the ...

    Comment?

  18. Onconova Therapeutics Inc. (ONTX) Given $6.00 Consensus Price Target by BrokeragesRead the original story w/Photo

    17 hrs ago | Daily Political

    ... is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company ...

    Comment?

  19. Merck & Co., Inc. (MRK) Gets Coveted Approval For KeytrudaRead the original story w/Photo

    17 hrs ago | Insider Monkey

    ... The acceptance of Keytruda's application also represents a significant milestone for the field of immuno-oncology. Dr. Roger M. Perlmutter, President, Merck Research Laboratories refers to it as an additional indication of Merck's commitment to the ...

    Comment?

  20. Vascular Biogenics (VBLT) - Research Analysts' Recent Ratings ChangesRead the original story w/Photo

    18 hrs ago | AmericanBankingNews.com

    ... discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead oncology candidate VB-111, is a gene-based biologic which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an ...

    Comment?